Seroepidemiology of rubella in northern Greece
- 8 July 2004
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 23 (8)
- https://doi.org/10.1007/s10096-004-1172-y
Abstract
In light of two rubella outbreaks in northern Greece during the last decade (1993 and 1999) and periodic changes to the immunization strategy, the present study was conducted to determine the current status of rubella immunity in this region. Among the 729 subjects studied the total vaccination rate was 30.4% and the seroprevalence rate was 82.4% (odds ratio, 0.618; 95% confidence interval, 0.415–0.921). A higher seroprevalence (83.2%) was observed among people born before 1989, when the national rubella immunization program was introduced, compared to the individuals born after 1989 (67.1%; P=0.000). Among women of reproductive age (i.e. 16–40 years), who represented 69.6% of the study population, 10.3% were susceptible to rubella and only 16.4% were vaccinated. The results indicate a comprehensive policy is still needed in order to eliminate rubella and congenital rubella syndrome in Greece.Keywords
This publication has 5 references indexed in Scilit:
- The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubellaEpidemiology and Infection, 2000
- Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review How does herd immunity work?BMJ, 1999
- Effect of selective vaccination on rubella susceptibility and infection in pregnancy.BMJ, 1985
- The History and Medical Consequences of RubellaClinical Infectious Diseases, 1985
- CONSEQUENCES OF CONFIRMED MATERNAL RUBELLA AT SUCCESSIVE STAGES OF PREGNANCYThe Lancet, 1982